Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Idiopathic Sudden Sensorineural Hearing Loss
NCT07045883Active, not recruiting
- Sponsor
- Xiamen University Zhongshan Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label trial of cholecalciferol in idiopathic sudden sensorineural hearing loss (ISSNHL) (2 arms), sponsored by Xiamen University Zhongshan Hospital. Primary endpoint: Vitamin D deficiency as a prognostic factor in ISSNHL at 14 weeks. Started Jun 2025; status: active, not recruiting.
02
Drugs
cholecalciferol
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on NCT07045883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045883.